Advances in stem cell research for the treatment of primary hypogonadism
Nature Reviews Urology, Published online: 29 June 2021; doi:10.1038/s41585-021-00480-2Testosterone replacement therapy for the treatment of primary hypogonadism in men is associated with multiple adverse effects including infertility. The re-establishment of testosterone-producing cell lineages using stem-cell-based therapy has had promising results in pre-clinical studies and could be used in transplantation therapy.
Source: Nature Reviews Urology - Category: Urology & Nephrology Authors: Lu Li Vassilios Papadopoulos Source Type: research
More News: Infertility | Low Testosterone | Reproduction Medicine | Stem Cell Therapy | Stem Cells | Study | Transplants | Urology & Nephrology